Skip to main content
Premium Trial:

Request an Annual Quote

Population Genetics Gets Funding under International Leukemia Study

NEW YORK (GenomeWeb News) – Population Genetics said today that it has received funding to support a European-backed international research consortium studying genetic risk among children for relapse of acute lymphoblastic leukemia, or ALL.

Funded with €6 million ($7.5 million) from the European Commission, the five-year effort, called the IntReALL consortium, will engage 23 research teams seeking to develop a standardized treatment for this malignant childhood disease, an effort that will involve gathering, banking, and studying DNA from Europe, Japan, Israel, and Australia.

Population Genetics Technologies will use its GenomePooling workflows to study the biobanked DNA samples and identify and validate associations between genetic risk factors and treatment efficacy. The partners hope to use this knowledge to identify which patients will benefit most from reduced-toxicity treatments and to develop a genetically stratified basis for conducting randomized trials of potential new treatments.

"This study presents a unique but highly complex opportunity to interrogate a large dataset of this malignant disease. Population Genetics has shown its expertise in the field of large population gene association studies which would probably otherwise be too costly and error-prone for clinical researchers seeking to test hypotheses," University of Manchester Professor of Pediatric Oncology and leader of the study Vaskar Saha said in a statement.

Population Genetics CEO Alan Schafer said the IntReALL study will enable the company to "demonstrate that our population-scale association study techniques can be applied to complex solid lymph node tumors, in addition to other areas of disease genetics in which we currently work."

The Cambridge, UK-based company did not disclose the amount of funding it has been awarded under the project.

The Scan

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.

Study Points to Benefits of Local Consolidative Therapy, Targeted Treatments in Cancer Care

In JCO Precision Oncology, researchers report that local consolidative therapy combined with molecularly targeted treatments could improve survival for some lung cancer patients.

Genetic Variants That Lower LDL Cholesterol Linked to Reduced Heart Disease Risk

Rare variants in two genes that lower LDL cholesterol are also associated with a decreased risk of coronary heart disease, according to a new JAMA Cardiology study.

Study Links Evolution of Longevity, Social Organization in Mammals

With the help of comparative phylogenetics and transcriptomics, researchers in Nature Communications see ties between lifespan and social organization in mammals.